Regardless of these limitations, this network of microRNAs may potentially be used as a therapy to balance the levels of IL-6 and IL-8 in asthma with a low off-target effect (as shown in Figure 5, Figure 6, Figure 7, Figure 8 and Figure 9). This evidence concerns the gene CXCL8 and asthma.